Nikolaos P. Nanis - Mar 19, 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Chief Technology Officer
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Mar 19, 2024
Transactions value $
$0
Form type
4
Date filed
3/20/2024, 04:11 PM
Previous filing
Mar 5, 2024
Next filing
Apr 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Award $0 +37.9K $0.00 37.9K Mar 19, 2024 Common Stock 37.9K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2 One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.